非酒精性脂肪肝痰瘀证与纤溶状态的关系

作者	单位
邓银泉	浙江大学医学院附属第一医院杭州310003
范小芬	浙江大学医学院附属第一医院杭州310003
李剑平	浙江大学医学院附属第一医院杭州310003

摘要点击次数: 1296

全文下载次数: 1463

中文摘要:

目的探讨非酒精性脂肪肝 (non alcoholicfattyliver,NAFL)痰瘀证与纤溶状态的关系。方法将符合NAFL诊断的患者辨证分为痰瘀证组 18例与非痰瘀证组 5 2例 ,并设健康人对照组 2 8名 ,比较各组纤溶酶原 (plasminogen ,PLG)、组织纤溶酶原激活物 (tissueplasminogenactivator,t PA)、1型纤溶酶原激活物抑制物 (plasminogenactivatorinhibitor 1,PAI 1)、D 二聚体的变化。结果NAFL患者t PA活性明显低于健康人对照组 (P <0 0 1) ,PLG、PAI 1活性明显高于健康人对照组 (P <0 0 5 ) ;与非痰瘀证组比较 ,痰瘀证组患者t PA活性明显降低 ,PLG、PAI 1活性明显升高 (P <0 0 1) ,而D 二聚体差异无显著性 (P >0 0 5 )。结论NAFL痰瘀证患者纤溶活性明显降低 ,存在不同程度的微循环障碍或高黏状态 ,采用化痰散瘀治疗有积极意义。

英文摘要:

Objective To explore the relationship between phlegm stasis Syndrome (PSS) and the fibrinolytic status in patients with non alcoholic fatty liver (NAFL). Methods Seventy patients with NAFL were divided into the PSS group and non PSS group according to TCM Syndrome typing, and a control group consisted of 28 healthy subjects was set up. Levels of plasminogen (PLG), tissue plasminogen activator (t PA), plasminogen activator inhibitor 1 (PAI 1) and D dimer were determined and compared. Results The activity of t PA in NAFL patients was significantly lower than that in the control group ( P <005), and PLG and PAI 1 were significantly higher than those in the control group ( P <005), and PLG and PAI 1 were significantly higher than those in the control group ( TBX〗P <005). In respect to the TCM Syndrome typing, in patients of PSS, t PA was significantly lower and PLG, PAI 1 were significantly higher than those in patients of non PSS ( P <005 or P <001), while D dimer was insignificantly different between patients of the two Syndrome types ( P >005). Conclusion NAFL patients of PSS type shows significant lower of fibrinolytic activity, indicating that there is certain degree of microcirculatory disturbance and hyper viscosity state, so the application of dissolving phlegm and dispelling stasis principle in treating NAFL is significant.

关闭